Myopia, or nearsightedness, is an increasingly common refractive error, especially among children. As more people become aware of this condition, several myths about myopia continue to spread.
At Excel Eyecare OD PA, we’re here to clear up these misconceptions and provide the facts about effective myopia management.
Separating Fact from Fiction
Myth 1: "Myopia Will Stop Progressing On Its Own"
One common myth is that myopia will eventually stop worsening as a child grows older.
Truth: while it’s true that myopia tends to stabilize in early adulthood, it often worsens as children grow, increasing their need for stronger prescriptions. At Excel Eyecare OD PA, we offer effective myopia management treatments tailored to each child’s unique lifestyle and vision requirements.
Myth 2: "Glasses Are the Only Solution"
Just give your child a pair of glasses, right?
Truth: while glasses are essential for clear vision, they don’t address the root cause of myopia progression and do nothing to stop it from worsening. At Excel Eyecare OD PA, we provide advanced myopia management plans that go beyond just glasses. Our plans include several safe and effective treatments, including multifocal lenses specifically designed to correct vision and slow down myopia progression in children.
Myth 3: "Myopia Can’t Be Controlled"
There seems to be a common belief that myopia cannot be managed.
Truth: modern treatments can significantly slow the progression of myopia and reduce the risk of sight-threatening diseases in adulthood. With early intervention and treatments like multifocal lenses, parents can help reduce the risk of severe myopia and eye diseases in their child’s future. Regular eye exams and customized management plans are key to protecting long-term vision.
Myopia Management with Excel Eyecare OD PA
Don’t let these myths hold you back from managing your child’s myopia effectively. At Excel Eyecare OD PA, we offer personalized myopia management plans to give your child the healthy, vibrant vision they deserve. Schedule their myopia consultation here.